Anavex Life Sciences Corp (AVXL)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | DONHAUSER, PETER D.O. | Director | Stock Option (Right to Buy) | Acquisition | 50,000 | $0 |
| Nov 3, 2026 | KELLMEYER, TERRIE | Director, President and CEO | Stock Option (Right to Buy) | Acquisition | 200,000 | $0 |
| Nov 3, 2026 | PAEGER, AXEL | Director | Stock Option (Right to Buy) | Acquisition | 50,000 | $0 |
| Nov 3, 2026 | VELDEN, CLAUS VANDER | Director | Stock Option (Right to Buy) | Acquisition | 50,000 | $0 |
| Sep 24, 2026 | BOENISCH, SANDRA | PFO & Treasurer | Stock Option (Right to Buy) | Acquisition | 25,000 | $0 |
| Sep 24, 2026 | BOENISCH, SANDRA | PFO & Treasurer | Stock Option (Right to Buy) | Acquisition | 20,000 | $0 |
| Jan 6, 2026 | BOENISCH, SANDRA | PFO & Treasurer | Stock Option (Right to Buy) | Acquisition | 12,500 | $0 |
| Jan 6, 2026 | MISSLING, CHRISTOPHER U | Director, President and CEO | Stock Option (Right to Buy) | Acquisition | 125,000 | $0 |